Pozzo-Miller L - Search Results

1

Gold WA, Percy AK, Neul JL, Cobb SR, Pozzo-Miller L, Issar JK, Ben-Zeev B, Vignoli A, Kaufmann WE. Gold WA, et al. Among authors: pozzo miller l. Nat Rev Dis Primers. 2024 Nov 7;10(1):84. doi: 10.1038/s41572-024-00568-0. Nat Rev Dis Primers. 2024. PMID: 39511247 Review.

2

Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations.

Chapleau CA, Calfa GD, Lane MC, Albertson AJ, Larimore JL, Kudo S, Armstrong DL, Percy AK, Pozzo-Miller L. Chapleau CA, et al. Neurobiol Dis. 2009 Aug;35(2):219-33. doi: 10.1016/j.nbd.2009.05.001. Epub 2009 May 12. Neurobiol Dis. 2009. PMID: 19442733 Free PMC article.

3

Experimental models of Rett syndrome based on Mecp2 dysfunction.

Calfa G, Percy AK, Pozzo-Miller L. Calfa G, et al. Exp Biol Med (Maywood). 2011 Jan;236(1):3-19. doi: 10.1258/ebm.2010.010261. Exp Biol Med (Maywood). 2011. PMID: 21239731 Free PMC article. Review.

4

Evaluation of current pharmacological treatment options in the management of Rett syndrome: from the present to future therapeutic alternatives.

Chapleau CA, Lane J, Pozzo-Miller L, Percy AK. Chapleau CA, et al. Curr Clin Pharmacol. 2013 Nov;8(4):358-69. doi: 10.2174/15748847113086660069. Curr Clin Pharmacol. 2013. PMID: 24050745 Free PMC article. Review.

5

Rett Syndrome: Reaching for Clinical Trials.

Pozzo-Miller L, Pati S, Percy AK. Pozzo-Miller L, et al. Neurotherapeutics. 2015 Jul;12(3):631-40. doi: 10.1007/s13311-015-0353-y. Neurotherapeutics. 2015. PMID: 25861995 Free PMC article. Review.

6

Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations.

Larimore JL, Chapleau CA, Kudo S, Theibert A, Percy AK, Pozzo-Miller L. Larimore JL, et al. Neurobiol Dis. 2009 May;34(2):199-211. doi: 10.1016/j.nbd.2008.12.011. Epub 2009 Jan 3. Neurobiol Dis. 2009. PMID: 19217433 Free PMC article.

7

Hippocampal CA1 pyramidal neurons of Mecp2 mutant mice show a dendritic spine phenotype only in the presymptomatic stage.

Chapleau CA, Boggio EM, Calfa G, Percy AK, Giustetto M, Pozzo-Miller L. Chapleau CA, et al. Neural Plast. 2012;2012:976164. doi: 10.1155/2012/976164. Epub 2012 Jul 30. Neural Plast. 2012. PMID: 22919518 Free PMC article.

8

Recent Progress in Rett Syndrome and MeCP2 Dysfunction: Assessment of Potential Treatment Options.

Chapleau CA, Lane J, Larimore J, Li W, Pozzo-Miller L, Percy AK. Chapleau CA, et al. Future Neurol. 2013 Jan 1;8(1):10.2217/fnl.12.79. doi: 10.2217/fnl.12.79. Future Neurol. 2013. PMID: 24348096 Free PMC article.

9

Preclinical research in Rett syndrome: setting the foundation for translational success.

Katz DM, Berger-Sweeney JE, Eubanks JH, Justice MJ, Neul JL, Pozzo-Miller L, Blue ME, Christian D, Crawley JN, Giustetto M, Guy J, Howell CJ, Kron M, Nelson SB, Samaco RC, Schaevitz LR, St Hillaire-Clarke C, Young JL, Zoghbi HY, Mamounas LA. Katz DM, et al. Dis Model Mech. 2012 Nov;5(6):733-45. doi: 10.1242/dmm.011007. Dis Model Mech. 2012. PMID: 23115203 Free PMC article. Review.

10

Insulinotropic treatments exacerbate metabolic syndrome in mice lacking MeCP2 function.

Pitcher MR, Ward CS, Arvide EM, Chapleau CA, Pozzo-Miller L, Hoeflich A, Sivaramakrishnan M, Saenger S, Metzger F, Neul JL. Pitcher MR, et al. Hum Mol Genet. 2013 Jul 1;22(13):2626-33. doi: 10.1093/hmg/ddt111. Epub 2013 Mar 5. Hum Mol Genet. 2013. PMID: 23462290 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters